The iShares U.S. Pharmaceuticals ETF (NYSE ARCA: IHE) is an investment fund that focuses on the pharmaceuticals sector of the U.S. equity market. It aims to track the performance of its underlying index, which is comprised of pharmaceutical companies that manufacture prescription or over-the-counter drugs, vaccines, and other related products.
The fund's investment strategy involves allocating at least 80% of its assets to the component securities of its underlying index, as well as other investments that have similar economic characteristics. This approach allows the fund to closely mirror the performance of the pharmaceuticals sector, providing investors with targeted exposure to this specific industry.
As a non-diversified fund, the iShares U.S. Pharmaceuticals ETF may invest a significant portion of its assets in a smaller number of securities, which can result in higher volatility compared to a diversified fund. However, this concentrated approach can also provide investors with the potential for higher returns if the pharmaceuticals sector performs well.
The fund is managed by BlackRock, a leading global investment management company, and is listed on the NYSE ARCA exchange under the ticker symbol IHE. For more information about the fund, investors can visit the iShares website at http://www.ishares.com.
The fund is domiciled in the United States, which means it is subject to U.S. regulations and tax laws. This can impact the fund's performance and the tax implications for investors, so it's essential to consult with a financial advisor or tax professional before investing.